LUMOSA THERAPEUTICS CO (ROCO:6535) 3-Year EBITDA Growth Rate : 16.20% (As of Mar. 2024)

View and export this data going back to 2015. Start your Free Trial

What is LUMOSA THERAPEUTICS CO 3-Year EBITDA Growth Rate?

LUMOSA THERAPEUTICS CO's EBITDA per Share for the three months ended in Mar. 2024 was NT$-0.71.

During the past 3 years, the average EBITDA Per Share Growth Rate was 16.20% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

During the past 12 years, the highest 3-Year average EBITDA Per Share Growth Rate of LUMOSA THERAPEUTICS CO was 40.00% per year. The lowest was -44.00% per year. And the median was 1.90% per year.

Competitive Comparison of LUMOSA THERAPEUTICS CO's 3-Year EBITDA Growth Rate

For the Biotechnology subindustry, LUMOSA THERAPEUTICS CO's 3-Year EBITDA Growth Rate, along with its competitors' market caps and 3-Year EBITDA Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

LUMOSA THERAPEUTICS CO's 3-Year EBITDA Growth Rate Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, LUMOSA THERAPEUTICS CO's 3-Year EBITDA Growth Rate distribution charts can be found below:

* The bar in red indicates where LUMOSA THERAPEUTICS CO's 3-Year EBITDA Growth Rate falls into.

LUMOSA THERAPEUTICS CO 3-Year EBITDA Growth Rate Calculation

This is the 3-year average growth rate of EBITDA per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

LUMOSA THERAPEUTICS CO (ROCO:6535) 3-Year EBITDA Growth Rate Explanation

EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.

Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.

LUMOSA THERAPEUTICS CO 3-Year EBITDA Growth Rate Related Terms

Thank you for viewing the detailed overview of LUMOSA THERAPEUTICS CO's 3-Year EBITDA Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

LUMOSA THERAPEUTICS CO (ROCO:6535) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » LUMOSA THERAPEUTICS CO LTD (ROCO:6535) » Definitions » 3-Year EBITDA Growth Rate

Comparable Companies

Traded in Other Exchanges

N/A

Address

Yuanyuan Street, 4th Floor, No. 3-2, Nangang District, Taipei, TWN, 11503

Website

https://www.lumosa.com.tw

LUMOSA THERAPEUTICS CO LTD develops new drugs. The company is engaged in the development of drugs for unmet medical needs in the fields of CNS, oncology, and inflammatory diseases. Geographically, it derives a majority of its revenue from Asia and also has a presence in Taiwan and America. Its product portfolio includes LT - 1001 and LT - 3001 for Analgesic Injection and Novel Small Molecules for the Treatment of Acute Ischemic Stroke.

LUMOSA THERAPEUTICS CO (ROCO:6535) Headlines

No Headlines